FIELD: medicine; pharmaceuticals.
SUBSTANCE: treatment of pulmonary arterial hypertension. The use of dinitrosyl iron complex with glutathione-GS {(GS)2Fe2(NO)4} as an hypotensive agent with NO-dependent vasodilation for the treatment of pulmonary arterial hypertension by intravenous administration (PAH) is disclosed.
EFFECT: effective treatment of patients with pulmonary arterial hypertension.
1 cl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING PULMONARY HYPERTENSION | 2023 |
|
RU2813890C1 |
WATER-SOLUBLE COMPOSITION, POSSESSIVE PROPERTIES OF CARDIO-PROTECTOR | 2010 |
|
RU2438698C1 |
METHODS OF TREATING PULMONARY HYPERTENSION | 2012 |
|
RU2599490C2 |
METHOD OF ANAESTHESIA FOR CAESAREAN SECTION IN PREGNANT WOMEN WITH EISENMENGER SYNDROME | 2023 |
|
RU2823109C1 |
METHOD OF ACCESS TO LARGE VEINS OF UPPER EXTREMITIES (VBASILICA AND VCEPHALILCA) FOR CARRYING OUT DIAGNOSTIC AND THERAPETIC INTERVENTIONAL INTERFERENCES | 2016 |
|
RU2613562C1 |
USE OF BINUCLEAR SULPHUR-NITROSYL CATIONIC IRON COMPLEX AS VASODILATATOR | 2010 |
|
RU2460531C2 |
METHOD DETERMINING TACTICS OF CARRYING OUT OF MEDICAL ACTIONS AT PATIENTS WITH METABOLIC SYNDROME AGAINST ARTERIAL HYPERTENSIA | 2007 |
|
RU2337612C1 |
METHOD OF PREVENTING PULMONARY HYPERTENSION CRISES AFTER CORRECTION OF CONGENITAL HEART DISEASES IN CHILDREN | 2008 |
|
RU2391096C1 |
METHOD OF PREVENTIVE TREATMENT OF STROKE | 2006 |
|
RU2324481C1 |
METHOD OF TREATING PATIENTS WITH CARDIOVASCULAR DISEASES | 2013 |
|
RU2543468C2 |
Authors
Dates
2023-10-04—Published
2022-11-08—Filed